Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Cameron

Showing results (211-220 of 286) with videos related to

Pageof 29
Sort By:
Annals of Surgery|May 15, 2019
Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal AdenocarcinomaVincent P Groot, Georgios Gemenetzis, Alex B Blair, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2006
Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trialJordan M Winter, John L Cameron, Kurtis A Campbell, et al.
The American Journal of Pathology|November 5, 2002
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasiaN Tjarda van Heek, Alan K Meeker, Scott E Kern, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 14, 2011
Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experiencePeter J Kneuertz, Steven C Cunningham, John L Cameron, et al.
World Journal of Surgery|July 21, 2022
Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant TherapyGabriel D Ivey, Sami Shoucair, Daniel J Delitto, et al.
Annals of Surgery|September 16, 2022
A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cells After Resection of Pancreatic Ductal AdenocarcinomaAmmar A Javed, Anne Floortje van Oosten, Joseph R Habib, et al.
World Journal of Surgery|January 7, 2022
Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant TherapyAmmar A Javed, Ding Ding, Erum Baig, et al.
Annals of Surgery|June 18, 2025
The Mutational Status of Driver Genes in Patients with Resected Pancreatic Ductal Adenocarcinoma is Associated with Pathological Characteristics and Overall SurvivalBrady A Campbell, Dario Solinas, Amanda L Blackford, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2006
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experienceJordan M Winter, John L Cameron, Kurtis A Campbell, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 8, 2012
Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancerCharles C Hsu, Christopher L Wolfgang, Daniel A Laheru, et al.
Pageof 29

Showing results (211-220 of 286) with videos related to

Sort By:
Pageof 29
Annals of Surgery|May 15, 2019
Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal AdenocarcinomaVincent P Groot, Georgios Gemenetzis, Alex B Blair, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2006
Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trialJordan M Winter, John L Cameron, Kurtis A Campbell, et al.
The American Journal of Pathology|November 5, 2002
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasiaN Tjarda van Heek, Alan K Meeker, Scott E Kern, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 14, 2011
Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experiencePeter J Kneuertz, Steven C Cunningham, John L Cameron, et al.
World Journal of Surgery|July 21, 2022
Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant TherapyGabriel D Ivey, Sami Shoucair, Daniel J Delitto, et al.
Annals of Surgery|September 16, 2022
A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cells After Resection of Pancreatic Ductal AdenocarcinomaAmmar A Javed, Anne Floortje van Oosten, Joseph R Habib, et al.
World Journal of Surgery|January 7, 2022
Accurate Nodal Staging in Pancreatic Cancer in the Era of Neoadjuvant TherapyAmmar A Javed, Ding Ding, Erum Baig, et al.
Annals of Surgery|June 18, 2025
The Mutational Status of Driver Genes in Patients with Resected Pancreatic Ductal Adenocarcinoma is Associated with Pathological Characteristics and Overall SurvivalBrady A Campbell, Dario Solinas, Amanda L Blackford, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2006
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experienceJordan M Winter, John L Cameron, Kurtis A Campbell, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 8, 2012
Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancerCharles C Hsu, Christopher L Wolfgang, Daniel A Laheru, et al.
Pageof 29